193 related articles for article (PubMed ID: 32247541)
1. Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment.
Tomomatsu K; Sugino Y; Okada N; Tanaka J; Oguma T; Asano K
Allergol Int; 2020 Oct; 69(4):636-638. PubMed ID: 32247541
[No Abstract] [Full Text] [Related]
2. Allergic bronchopulmonary aspergillosis successfully treated with benralizumab.
Soeda S; Kono Y; Tsuzuki R; Yamawaki S; Katsube O; To M; To Y
J Allergy Clin Immunol Pract; 2019; 7(5):1633-1635. PubMed ID: 30513359
[No Abstract] [Full Text] [Related]
3. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
[No Abstract] [Full Text] [Related]
4. Allergic bronchopulmonary aspergillosis and omalizumab.
Tillie-Leblond I; Germaud P; Leroyer C; Tétu L; Girard F; Devouassoux G; Grignet JP; Prudhomme A; Dusser D; Wallaert B
Allergy; 2011 Sep; 66(9):1254-6. PubMed ID: 21517902
[No Abstract] [Full Text] [Related]
5. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
[No Abstract] [Full Text] [Related]
6. Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis.
Tashiro H; Takahashi K; Kurihara Y; Sadamatsu H; Kimura S; Sueoka-Aragane N
Allergol Int; 2021 Jan; 70(1):145-147. PubMed ID: 32917523
[No Abstract] [Full Text] [Related]
7. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
[TBL] [Abstract][Full Text] [Related]
8. Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Oda N; Miyahara N; Senoo S; Itano J; Taniguchi A; Morichika D; Fujii U; Maeda Y; Kiura K; Kanehiro A
Allergol Int; 2018 Oct; 67(4):521-523. PubMed ID: 29665990
[No Abstract] [Full Text] [Related]
9. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
Moss RB
Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
[TBL] [Abstract][Full Text] [Related]
10. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.
Soeda S; To M; Kono Y; Yamawaki S; Tsuzuki R; Katsube O; Watanabe N; To Y
Allergol Int; 2019 Jul; 68(3):377-379. PubMed ID: 30704844
[No Abstract] [Full Text] [Related]
11. [A case of allergic bronchopulmonary aspergillosis localized in one bronchial segment].
Osoreda H; Kobayashi H; Nagao H; Mikita K; Kanoh S; Motoyoshi K
Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):898-902. PubMed ID: 18051795
[TBL] [Abstract][Full Text] [Related]
12. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
Altman MC; Lenington J; Bronson S; Ayars AG
J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
[No Abstract] [Full Text] [Related]
13. Allergic bronchopulmonary aspergillosis in a lung transplant recipient treated with mepolizumab.
Ioakeim F; Abellan C; Casutt A; Lechartier B; Noirez L; Beigelman-Aubry C; Aubert JD; Balmpouzis Z; Koutsokera A
Clin Immunol; 2024 Jul; 264():110265. PubMed ID: 38801928
[TBL] [Abstract][Full Text] [Related]
14. Mepolizumab (Nucala) for severe eosinophilic asthma.
Med Lett Drugs Ther; 2016 Jan; 58(1486):11-2. PubMed ID: 26761344
[No Abstract] [Full Text] [Related]
15. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
Evans MO; Morris MJ; Coop CA; Evans SE
Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
[No Abstract] [Full Text] [Related]
16. High attenuation mucous plugs in allergic bronchopulmonary aspergillosis: CT appearance.
Goyal R; White CS; Templeton PA; Britt EJ; Rubin LJ
J Comput Assist Tomogr; 1992; 16(4):649-50. PubMed ID: 1629428
[TBL] [Abstract][Full Text] [Related]
17. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
Wolf BL; Johnson A
J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
[No Abstract] [Full Text] [Related]
18. Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma.
Moran AM; Ramakrishnan S; Borg CA; Connolly CM; Couillard S; Mwasuku CM; Pavord ID; Hinks TSC; Lehtimӓki L
Am J Respir Crit Care Med; 2020 Nov; 202(9):1314-1316. PubMed ID: 32584603
[No Abstract] [Full Text] [Related]
19. The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma.
Jelihovsky T
Histopathology; 1983 Mar; 7(2):153-67. PubMed ID: 6852779
[TBL] [Abstract][Full Text] [Related]
20. One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response.
Caminati M; Batani V; Guidolin L; Festi G; Senna G
Eur J Intern Med; 2022 May; 99():112-115. PubMed ID: 34998664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
